| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bc3c1b01e04a6525c35b0543ef26cdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2c89007c865520fcb4434b52d80cb37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_897b7fb168331379cbc260a412d2521f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-4833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N24-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48792 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2015-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a0a68e7eb2b68eab500caf4f13dde35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db3ea20e07a367b970a62903e0487bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82a64206a8d6a0d2f42eea97eb97944a |
| publicationDate |
2016-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016151415-A1 |
| titleOfInvention |
Pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals and method thereof |
| abstract |
A pharmaceutical composition of the present invention is used for improving health, cure abnormalities and degenerative disease; achieve anti-aging effect of therapy and therapeutic effect on mammals. The pharmaceutical composition includes a pharmaceutical carrier and an isotope selective ingredient including at least one of a chemical element and a chemical compound containing the chemical element whereby isotope distribution in the at least one of the chemical element and the chemical compound containing the chemical element is different from natural distribution of at least one of isotopes wherein the part of selected isotope of the chemical element ranges from 0 to 100%. A method of the present invention uses the inventive pharmaceutical composition to improve health, cure abnormalities and degenerative disease and achieve therapeutic effect on mammals. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10857180-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2023050325-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018296596-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022313731-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596650-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10226484-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021101569-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10183041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11730835-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11638721-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10799530-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484610-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11484550-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10933091-B1 |
| priorityDate |
2014-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |